According to this survey, the global Single-use Bioprocessing Systems market is estimated at USD 3440 million in 2022 and is projected to grow at a CAGR of 13.0% to USD 8090 million by 2028.

Single-use Bioprocessing Systems Market Overview

Single-use bioprocessing is a rapidly developing technology for the development of single-use bioprocessing equipment and accessories for manufacturing biopharmaceutical molecules such as recombinant proteins, monoclonal antibodies, vaccines, and stem cells. Bioprocessing utilizes living cells or their components such as enzymes, bacteria, etc. to obtain preferred products. The core idea behind the use of single-use bioprocessing technologies in bioprocessing is to reduce the costs associated with complex steps such as cleaning, sterilization, and maintenance of steel-based bioreactor systems.

Contrive Datum Insights has recently published the Single-use Bioprocessing Systems Market to its huge database which helps to shape the future of businesses by making well-informed business decisions. It offers a comprehensive analysis of various business aspects such as global market trends, recent technological advancements, market size, shares, and new innovations. Furthermore, this analytical data has been compiled through data exploratory techniques such as primary and secondary research. Moreover, an expert team of researchers throws light on various static and dynamic aspects of the global Single-use Bioprocessing Systems market.

Some of the key players profiled in the study are:

Different leading key players have been profiled to get better insights into the businesses. It offers detailed elaboration on different top-level industries which are functioning in global regions. It includes informative data such as company overview, contact information, and some significant strategies followed by key players: Danaher Corporation, Eppendorf AG, Finesse Solutions, GE Healthcare, Thermo Fisher Scientific, Broadley-James Corporation, Meissner Filtration Products, Merck Millipore, Parker Hannifin Corporation, PBS Biotech, Saint Gobain, Sartorius AG, Sentinel Proces, and others.

Industry Development:

• In March 2020, Danaher acquired the biopharmaceutical business from General Electric Company's Life Sciences segment. The company, called Cytiva, is an independent operating company within Danaher's Life Sciences segment.
• In September 2020, Thermo Fisher Scientific invested more than $475 million in new capabilities at its St. Louis facility to expand biologics development and manufacturing, cell and gene therapy capabilities, and drug product development capabilities.

What are the major Applications, Types, and Regions for the Single-use Bioprocessing Systems Market?

By Product

• Single-use media bags and containers
• Single-use assemblies
• Single-use bioreactors
• Disposable mixers
• Other products

By Application

• Filtration
• Storage
• Cell culture
• Mixing
• Purification

By End user

• Biopharmaceutical & Pharmaceutical companies
• Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)

Single-use Bioprocessing Systems Market Regional Insights:

North America will hold the leading revenue share of more than 32.9% in 2021, which can be attributed to the mature pharmaceutical and biomanufacturing industries and substantial R&D activities in the region. Likewise, the growing focus on vaccine production is driving the demand for single-use bioprocessing equipment to aid disease prevention measures in the region. Additionally, the presence of the Bioprocess Systems Alliance (BPSA) in North America to drive the adoption of single-use technology is expected to further boost the sales of single-use systems in the region.
Asia Pacific is anticipated to grow at the highest CAGR during the forecast period. The growing bioprocessing market in the region has attracted multiple investments from several global companies. These investments help serve major companies to build regional presence and capitalize on untapped avenues. Additionally, the growing interest of contract service providers to develop bases in APAC, coupled with the trend of CMOs implementing disposables, act as catalysts for continued investment by local and global companies. For example, in September 2021, Singapore saw the expansion of Lonza's drug development facility. The CDMO has enhanced capabilities to support the region's growing manufacturing needs.

Geographically, the global Single-use Bioprocessing Systems market has been analyzed in various regions such as North America, Europe, Asia-Pacific, Latin America, the Middle East, and India. The global region is dominating this market in the upcoming future.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Single-use Bioprocessing Systems Market Report Scope:

Report Attributes	Details
Growth Rate	CAGR of 13.0% from 2022 to 2030.
By Product	Single-use media bags and containers Single-use assemblies Single-use bioreactors Disposable mixers Other products
By Application	Filtration Storage Cell culture Mixing Purification
By End user	Biopharmaceutical & Pharmaceutical companies Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)
By Companies	Danaher Corporation, Eppendorf AG, Finesse Solutions, GE Healthcare, Thermo Fisher Scientific, Broadley-James Corporation, Meissner Filtration Products, Merck Millipore, Parker Hannifin Corporation, PBS Biotech, Saint Gobain, Sartorius AG, Sentinel Proces
Regions and Countries Covered	North America: (US, Canada, Mexico, Rest of North America) Europe(Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe) Asia-Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific) The Middle East & Africa(Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa) Latin America(Brazil, Argentina, Rest of Latin America) Rest Of the World
Base Year	2022
Historical Year	2017 to 2022
Forecast Year	2023 to 2030

Frequently Asked Questions (FAQ) about the Single-use Bioprocessing Systems market:

What is the CAGR of the global Single-use Bioprocessing Systems market?

The Single-use Bioprocessing Systems Market is growing at a CAGR of 13.0% during the forecast period.

Which region would offer high growth for vendors in the Single-use Bioprocessing Systems market?

North America will hold the leading revenue share of more than 32.9% in 2021.

Which Is the Most potential market segment?

By Product

• Single-use media bags and containers
• Single-use assemblies
• Single-use bioreactors
• Disposable mixers
• Other products

By Application

• Filtration
• Storage
• Cell culture
• Mixing
• Purification

Which are the top industry players in the Single-use Bioprocessing Systems market?

Danaher Corporation, Eppendorf AG, Finesse Solutions, GE Healthcare, Thermo Fisher Scientific, Broadley-James Corporation, Meissner Filtration Products, Merck Millipore, Parker Hannifin Corporation, PBS Biotech, Saint Gobain, Sartorius AG, Sentinel Proces

All of our reports are custom to your company's needs to some extent and we offer 5 hours of free consultation time with each report purchase, which will allow you to request any additional data to custom the report to your needs.